bioRxiv ScienceSearch

bioRxiv · 10.1101/2020.09.02.280586

Health professionals over estimation of knowledge on snakebite management, a threat to survival of snake bite victims - A cross-sectional study in Ghana.

Abstract

BackgroundAccording to the World Health Organization, snakebites, a common occupational hazard in developing countries accounts an annual loss of between 81,000 and 139, 000 lives following 5 million of bites of which 2.7 million results in envenomation. Since snakebite associated morbidity and mortality is more prevalent in agriculture economies such as Ghana, health professionals should be optimally knowledgeable on how to manage incidence of snakebites. Lack of knowledge or overestimation of a professionals knowledge can be affects heath delivery especially for emergency situations such as snakebites. The three (3) Tongu districts South Eastern Ghana which are rurally situated with agriculture as the major source of livelihood for their inhabitants are prone to snakebite incidence hence the need to assess whether the health professionals in these districts are well equipped by way of knowledge to handle such emergencies and whether they are able to rightly estimate their knowledge with regards to snakebite management. Methodology/Principal findingsData was collected using a de novo semi-structured questionnaire administered through google form whose link was sent via to 186 health workers made up of nurses, midwives, physician assistants, medical doctors, pharmacists, and pharmacy technicians. This data was analyzed using Statistical Package for the Social Sciences (SPSS) Version 25. Association between variables was determined using the appropriate tools where necessary, using a confidence interval of 95% and significance assumed when p [≤] 0.05. This study found male health workers significantly more knowledgeable about snakebite management (11.53{+/-}5.67 vrs 9.64{+/-}5.46; p = 0.022) but it was the females who overestimated their knowledge level (27.9% vrs 24.1%). The medical doctors exhibited the best knowledge on snakebite management with the registered general nurses least knowledgeable. Although most professionals overestimated their knowledge, the registered general nurses were the worst at that (53.7%). Overall knowledge of health care professionals on snakebite management was below average [10.60{+/-}5.62/22 (48.2%)] but previous in-service training and involvement in management of snakebite were associated with better knowledge. Respondents who had no previous training overestimated their knowledge level compared to those who had some post qualification training on snakebite management (7.5% vrs 38.1%). Greatest knowledge deficit of respondents was on the management of ASV associated adverse reactions. ConclusionHealth workers in rural Ghana overestimated their knowledge about snakebite management although their knowledge was low. Training schools therefore need to incorporate snakebite management in their curriculum and health authorities should also expose health workers to more in-service training on this neglected tropical disease. Author summaryWorld Health Organization estimates that every year between 81,000 and 139,000 die due snake bites across the world. Mismanagement of snakebites can result in increased disabilities and death if not handled by knowledgeable health workers. This study assessed if various categories of health workers made up of professionals from the medical, pharmaceutical and nursing categories in the three neighbouring Tongu districts in Ghana have the appropriate level of knowledge on snakebite management. Using a newly developed questionnaire, data was collected from the respondents using google forms sent to their WhatsApp platforms. Data was then analyzed using Statistical Package for the Social Sciences (SPSS) Version 25. Results were presented in the form of tables and association between the variables also determined. The level of knowledge of sampled health workers on snakebite was below average especially among the nursing professionals. However, those who had some previous post qualification training on snakebite management exhibited a significant superior knowledge and least overestimated their knowledge hence policy makers should through workshops equip health workers especially the nurses on snakebites so that rural dwellers whose health care needs are mainly attended to by nurses can be better managed when they suffer snakebites.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ameade, E. P. K., Bonney, I., Boateng, E. T.. 2020-09-03. Health professionals over estimation of knowledge on snakebite management, a threat to survival of snake bite victims - A cross-sectional study in Ghana.. https://doi.org/10.1101/2020.09.02.280586

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

Antisense oligonucleotides (ASOs) are a powerful therapeutic modality, but their full potential is hindered by pharmacokinetic properties that affect tissue and cellular delivery. Lipid conjugation is increasingly used to modulate ASO's biodistribution and promote extrahepatic activity, yet lipid dependent effects on in vivo functional delivery, particularly in the central nervous system (CNS), remain less explored. Here, we performed a side by side in vivo comparison of cholesterol, palmitic acid (C16:0), docosanoic acid (C22:0), and eicosapentaenoic acid (C20:5) conjugated to a fully phosphorothioated 3 10 3 LNA gapmer ASO targeting the Malat1 long non coding RNA. Lipid-ASO conjugates were administered systemically or locally in the brain of mice and evaluated for tissue level and cellular level distribution by imaging, qPCR and single-cell RNA sequencing, simultaneously annotating cell origin and global transcriptional changes within the cell. Following systemic administration in mice, lipid conjugation improved overall multi organ efficacy compared to unconjugated ASO, but with pronounced tissue specific differences. Single cell sequencing of liver and heart transcriptomes revealed lipid dependent cellular uptake patterns and transcriptional responses distinct from administration of unconjugated ASO. After intracerebroventricular administration, selected fatty acid conjugates enhanced silencing in deep brain regions such as the striatum, whereas cholesterol conjugation impaired functional delivery despite increased CNS retention. Light-sheet microscopy showed restricted parenchymal penetration of cholesterol ASOs compared with broader but heterogeneous distribution of palmitic acid conjugate. Together, these findings demonstrate that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context specific lipid design in ASO therapeutic development.

pharmacology and toxicology

Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment

Small interfering RNA (siRNA) enables precise post-transcriptional gene silencing for refractory diseases, yet its clinical translation remains limited by the lack of safe and efficient delivery vectors. Inspired by the dissymmetric alkyl chain architecture of natural membrane phospholipids, we designed and synthesized 34 novel ionizable lipids with dissymmetric hydrophobic tails and formulated them into lipid nanoparticles (LNPs). Through systematic physicochemical and biological assessments, we established clear structure-activity relationships and identified two lead LNPs (O14-LNP, H18a-LNP) with superior endosomal escape capacity, enhanced in vivo gene silencing potency, and favorable biosafety relative to the clinical benchmark MC3-LNP. In both streptozotocin-induced and spontaneous db/db type 2 diabetes (T2D) mouse models, lead LNPs delivering ferroptosis-related siRNAs effectively ameliorated glucose and lipid metabolic disorders, restored islet function, and alleviated hepatic steatosis. This study not only lays a theoretical foundation for the rational design of novel ionizable lipids, but also validates the therapeutic potential of siRNA therapy targeting ferroptosis, providing a versatile delivery platform and targeted therapeutic strategy for the treatment of T2D.

pharmacology and toxicology

Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro

Background and PurposeRepurposing of currently available drugs is a valuable strategy to tackle the consequences of COVID-19. Recently, several studies have investigated the effect of psychoactive drugs on SARS-CoV-2 in cell culture models as well as in clinical practice. Our aim was to expand these studies and test some of these compounds against newly emerged variants. Experimental ApproachSeveral antidepressant drugs and antipsychotic drugs with different primary mechanisms of action were tested in ACE2/TMPRSS2-expressing human embryonic kidney cells against the infection by SARS-CoV-2 spike protein-dependent pseudoviruses. Some of these compounds were also tested in human lung epithelial cell line, Calu-1, against the first wave (B.1) lineage of SARS-CoV-2 and the variants of concern, B.1.1.7 and B.1.351. Key ResultsSeveral clinically used antidepressants, including fluoxetine, citalopram, reboxetine, imipramine, as well as antipsychotic compounds chlorpromazine, flupenthixol, and pimozide inhibited the infection by pseudotyped viruses with minimal effects on cell viability. The antiviral action of several of these drugs was verified in Calu-1 cells against the (B.1) lineage of SARS-CoV-2. By contrast, the anticonvulsant carbamazepine, and novel antidepressants ketamine and its derivatives as well as MAO and phosphodiesterase inhibitors phenelzine and rolipram, respectively, showed no activity in the pseudovirus model. Furthermore, fluoxetine remained effective against pseudo viruses with N501Y, K417N, and E484K spike mutations, and the VoC-1 (B.1.1.7) and VoC-2 (B.1.351) variants of SARS-CoV-2. Conclusion and ImplicationsOur study confirms previous data and extends information on the repurposing of these drugs to counteract SARS-CoV-2 infection including different variants of concern.

pharmacology and toxicology